Lantheus Holdings, Inc.

LNTH · XNAS

CIK 1521036fmd_0YBQ1CQ2TEB4NDA9KH19MCRCAVManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard

Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods

Ratios computed from the standardized statements. Select a value to open its proof.